1.Goh, KT. Epidemiological surveillance of communicable diseases in Singapore. Tokyo. Southeast Asian Medical Information Center. 1983; 56–88.
2.Goh, KT. Imported communicable diseases in Singapore. Ann Aca Med Singapore 1984; 13: 127–35.
3.Rice, PA, Baine, WB, Gangarosa, EJ. Salmonella typhi infections in the United States 1967–1972; increasing importance of international travellers. Am J Epidemiol 1977; 106: 160–6.
4.Moore, N, Perry, EL, Chard, ST. A survey by the sewage swabs method of latent enteric infection in an urban area. J Hyg 1952; 50: 137–56.
5.Koh, TS, Goh, KT. Enteric fever surveillance in Singapore. Sing Med J 1976; 17: 32–7.
6.Bauer, AW, Kirby, WMM, Sherris, JC, Turck, M. Antibiotic susceptibility testing by a standardised single disk method. Am J Clin Pathol 1966; 45: 493–6.
7.Anderson, ES, Williams, REO. Bacteriophage typing of enteric pathogens and staphylococci and its use in epidemiology. J Clin Pathol 1956; 9: 94–127.
8.Craigie, K, Felix, A. Typing of typhoid bacilli with Vi-bacteriophage. Lancet 1947; i: 823–7.
9.Yew, FS, Chew, SK, Goh, KT, Monteiro, EHA, Lim, YS. Typhoid fever in Singapore: a review of 370 cases. J Trop Med Hyg 1991; 94: 352–7.
10.Naylor, GRE. Incubation period and other features of food-borne and water-borne outbreaks of typhoid fever in relation to pathogenesis and genetics of resistance. Lancet 1983; i: 864–6.
11.Hornick, RB, Greisman, SE, Woodward, TE, DuPont, HL, Dawkins, AT, Snyder, MJ. Typhoid fever: pathogenesis and immunologic control. New Engl J Med 1970; 283: 739–46.
12.Christie, AB. Typhoid and paratyphoid fevers. In: Infectious diseases: epidemiology and clinical practice. 4th ed.New York: Churchill Livingston. 1987; 100–64.
13.Benavente, L, Gotuzzo, E, Guerra, J, Grados, O, Guerra, H, Bravo, N. Diagnosis of typhoid fever using a string capsule device. Trans R Soc Trop Med Hyg 1984; 78: 404–6.
14.Chau, PY, Tsang, RSW. Vi serology in screening of typhoid carriers: improved specificity by detection of Vi antibodies by counterimmunoelectrophoresis. J Hyg 1982; 89: 261–7.
15.Lanata, CF, Levine, MM, Ristori, C et al. , Vi serology in detection of chronic Salmonella typhi carriers in an endemic area. Lancet 1983; ii: 441–3.
16.Moss, KG, Fulmer, HS, Deuschle, KW. The present status of typhoid carriers in Kentucky. Arch Environ Hlth 1967; 14: 407–11.
17.Eisinger, AJ, Smith, JG. Acute renal failure after TAB and eholera vaccination. BMJ 1979; 1: 381–2.
18.Joo, I. Benefit versus risk factors in cholera and typhoid immunisation. International Symposium on Immunisation: benefit versus risk factors. Brussels 1978. Develop Biol Standard 1979; 43: 47–52.
19.Acharya, IL, Lowe, CU, Thapa, R et al. , Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N Engl J Med 1987; 317: 1101–4.
20.Levine, MM, Ferreccio, C, Black, RE, Germanier, R. Chilean Typhois Committee. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capasule formulation. Lancet 1987; i: 1049–52.
21.Yugoslav Typhoid Commission. A controlled field trial of the effectiveness of acetone-dried and inactivated and heat-phenol-inactivated typhoid vaccines in Yugoslavia. Bull WHO 1964; 30: 623–30.
22.Aschcroft, MT, Morrison-Ritchie, J, Nicholson, CC. Controlled field trials in British Guyana school children of heat-killed phenolised and acetone-killed lyophilised typhoid vaccines. Am J Hyg 1964; 79: 196–206.
23.Cvjetanovic, B, Uemura, K. The present status of field and laboratory studies of typhoid and paratyphoid vaccines, with special reference to studies sponsored by the World Health Organisation. Bull WHO 1965; 32: 29–36.